Aaron Kimson
Stock Analyst at Citizens JMP
(3.40)
# 2,350
Out of 5,040 analysts
95
Total ratings
54.9%
Success rate
6.1%
Average return
Main Sectors:
Stocks Rated by Aaron Kimson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NCNO nCino | Reiterated: Buy | $23 → $25 | $19.68 | +27.03% | 17 | Aug 26, 2026 | |
| EXFY Expensify | Upgraded: Buy | $3 | $2.30 | +30.43% | 13 | Aug 7, 2026 | |
| HNGE Hinge Health | Reiterated: Buy | $96 → $107 | $98.00 | +9.18% | 5 | Aug 5, 2026 | |
| PBI Pitney Bowes | Reiterated: Buy | $19 → $22 | $16.98 | +29.56% | 5 | Jul 31, 2026 | |
| GWRE Guidewire Software | Reiterated: Buy | $300 → $220 | $164.78 | +33.51% | 14 | Jun 5, 2026 | |
| BLND Blend Labs | Reiterated: Buy | $5 → $4 | $1.05 | +280.95% | 9 | May 8, 2026 | |
| PCOR Procore Technologies | Upgraded: Buy | $71 | $54.78 | +29.61% | 15 | Apr 29, 2026 | |
| PHR Phreesia | Downgraded: Hold | n/a | $10.66 | - | 10 | Apr 1, 2026 | |
| EQPT EquipmentShare.com | Initiated Coverage: Buy | $42 | $15.66 | +168.20% | 1 | Feb 17, 2026 | |
| EVCM EverCommerce | Reiterated: Buy | $15 | $9.06 | n/a | 6 | May 12, 2025 |
nCino
Aug 26, 2026
Reiterated: Buy
Price Target: $23 → $25
Current: $19.68
Upside: +27.03%
Expensify
Aug 7, 2026
Upgraded: Buy
Price Target: $3
Current: $2.30
Upside: +30.43%
Hinge Health
Aug 5, 2026
Reiterated: Buy
Price Target: $96 → $107
Current: $98.00
Upside: +9.18%
Pitney Bowes
Jul 31, 2026
Reiterated: Buy
Price Target: $19 → $22
Current: $16.98
Upside: +29.56%
Guidewire Software
Jun 5, 2026
Reiterated: Buy
Price Target: $300 → $220
Current: $164.78
Upside: +33.51%
Blend Labs
May 8, 2026
Reiterated: Buy
Price Target: $5 → $4
Current: $1.05
Upside: +280.95%
Procore Technologies
Apr 29, 2026
Upgraded: Buy
Price Target: $71
Current: $54.78
Upside: +29.61%
Phreesia
Apr 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $10.66
Upside: -
EquipmentShare.com
Feb 17, 2026
Initiated Coverage: Buy
Price Target: $42
Current: $15.66
Upside: +168.20%
EverCommerce
May 12, 2025
Reiterated: Buy
Price Target: $15
Current: $9.06
Upside: n/a